Detalles de la búsqueda
1.
Daratumumab-based regimens for patients with multiple myeloma plus extramedullary plasmacytomas or paraskeletal plasmacytomas: initial follow-up of an Italian multicenter observational clinical experience.
Ann Hematol;
2024 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38805036
2.
The role of ponatinib in adult BCR-ABL1 positive acute lymphoblastic leukemia after allogeneic transplantation: a real-life retrospective multicenter study.
Ann Hematol;
100(7): 1743-1753, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33774681
3.
Carfilzomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma patients: the real-life experience of Rete Ematologica Pugliese (REP).
Ann Hematol;
100(2): 429-436, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33161453
4.
Brentuximab vedotin prior to allogeneic stem cell transplantation increases survival in chemorefractory Hodgkin's lymphoma patients.
Ann Hematol;
98(6): 1449-1455, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30868307
5.
Brentuximab vedotin as salvage treatment in Hodgkin lymphoma naïve transplant patients or failing ASCT: the real life experience of Rete Ematologica Pugliese (REP).
Ann Hematol;
97(10): 1817-1824, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-30054707
6.
Oral antivirals against Sars-CoV-2 in multiple myeloma outpatients: a case series.
Recenti Prog Med;
114(1): 815-817, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36573533
7.
Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01.
Bone Marrow Transplant;
57(6): 949-958, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35413985
8.
[Treatment of early relapsed plasma cells leukemia after unrelated bone marrow transplant with KRD (carfilzomib, lenalidomide and dexamethasone): a case report.] / Trattamento della leucemia plasmacellulare in recidiva precoce dopo trapianto di midollo osseo allogenico da donatore non correlato con KRD (carfilzomib, lenalidomide e desametasone): un caso clinico.
Recenti Prog Med;
111(3): 160-166, 2020 Mar.
Artículo
en Italiano
| MEDLINE | ID: mdl-32157264
9.
Outcomes of Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Hodgkin Lymphomas: A Retrospective Multicenter Experience by the Rete Ematologica Pugliese (REP).
Clin Lymphoma Myeloma Leuk;
19(1): 35-40, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30293754
10.
Real-world evidence on the use of daratumumab, bortezomib and dexamethasone (DVd) in lenalidomide-refractory myeloma patients: subgroup analysis of the multicenter retrospective experience by "rete ematologica pugliese".
Leuk Lymphoma;
64(10): 1715-1718, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37417467
11.
Real world Italian experience of pomalidomide plus low-dose dexamethasone in the relapsed and refractory myeloma setting: extended follow-up of a retrospective multicenter study by the 'Rete Ematologica Pugliese E Basilicata'.
Leuk Lymphoma;
60(14): 3565-3568, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31286780
12.
Two novel heterozygote missense mutations of the ADAMTS13 gene in a child with recurrent thrombotic thrombocytopenic purpura.
Blood Transfus;
11(2): 241-4, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23058857
Resultados
1 -
12
de 12
1
Próxima >
>>